Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients	Immunosuppression; Vaccine Response Impaired	Recruiting	Not applicable	2026-04-09		NCT06262776

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Central Adelaide Local Health Network Incorporated	3
National Health and Medical Research Council, Australia	27
Royal Prince Alfred Hospital, Sydney, Australia	10
University of Adelaide	13

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Royal Adelaide Hospital	Adelaide	Australia	132

Clinical trials